CCT2 and malignant colon neoplasm: Mining databases like The Cancer Genome Atlas (TCGA) and the Human Protein Atlas confirmed our findings that high expression of CCT2 occurs in liver and prostate cancer and is associated with unfavorable prognosis (Supplementary Figure 1C, 1D and 1G, 1H) but in colon cancer, high levels of CCT2 were associated with improved prognosis, although this result was not statistically significant (Supplementary Figure 1J).